Skip to main content

Advertisement

SpringerLink
Log in

Management of new onset diabetes after transplantation (NODAT) with use of novel algorithm

  • Case Report
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Corticosteroids, calcineurin inhibitors, and mTOR inhibitors are often used as an immunosuppressant in patients after solid-organ transplant. These agents can lead to significant hyperglycemia which is called “New onset of diabetes after transplantation (NODAT)”. Tight-glycemic control in patients with NODAT not only reduces the risk of post-transplant infection and graft failure but also reduces the long-term morbidity and mortality. Management of patients with NODAT is complicated because changes in doses of immunosuppressant can lead to change in glycemic status. Here, we present a series of cases involving successful management of hyperglycemia among outpatient department (OPD) patients with NODAT using a novel algorithm which negates the glycemic effects of corticosteroids and calcineurin inhibitors. We have also described the basic components of the algorithm which can be useful for physicians who deal with NODAT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Davidson JA, Wilkinson A, International expert panel on new-onset diabetes after transplantation. New-onset diabetes after transplantation 2003 International Consensus Guidelines: an endocrinologist’s view. Diabetes Care [Internet]. 2004 Mar 1 [cited 2018 Jan 2];27(3):805–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14988309

    Article  Google Scholar 

  2. Montero N, Pascual J. Immunosuppression and post-transplant hyperglycemia. Curr Diabetes Rev [Internet]. 2015 [cited 2018 Jan 2];11(3):144–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25824238

  3. Lakhani O, Kumar S. Novel insulin algorithm for management of hyperglycemia in hospitalized patients with new onset of diabetes after transplant (NODAT): a pilot study : novel treatment for diabetes (posters). In: Endocrine Society’s 98th annual meeting and expo [internet]. Boston; 2016 [cited 2018 Jan 5]. Available from: https://doi.org/10.1210/endo-meetings.2016.DGM.22.FRI-692

  4. Sharif A, Baboolal K. Complications associated with new-onset diabetes after kidney transplantation. Nat Rev Nephrol [Internet]. 2011 Nov 15 [cited 2018 Jan 2];8(1):34–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22083141

    Article  Google Scholar 

  5. Rangel EB. Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions. Expert Opin Drug Metab Toxicol [Internet]. 2014 Nov 26 [cited 2018 Jan 2];10(11):1585–605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25255841

  6. Lakhani O, Kumar S, Tripathi S, Desai M, Seth C. Comparison of two protocols in the management of glucocorticoid-induced hyperglycemia among hospitalized patients. Indian J Endocrinol Metab [Internet]. 2017 [cited 2018 May 4];21(6):836. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29285445

    Article  CAS  Google Scholar 

  7. Lakhani OJ, Patel S. Successful management of a glucocorticoid-induced hyperglycemia in hospitalized patient with use of novel protocol. Int J Diabetes Dev Ctries [Internet] 2018 Jun 2 [cited 2018 Jun 3];1–5. Available from: https://doi.org/10.1007/s13410-018-0649-7

    Article  CAS  Google Scholar 

  8. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. 2009 [cited 2018 Jul 9]; Available from: http://www.kidney-international.org.

  9. Davies MJ, Alessio DAD, Fradkin J, Kernan WN, Mathieu C. Management of hyperglycaemia in type 2 diabetes , 2018. A consensus report by the American Diabetes Association ( ADA ) and the European Association for the Study of Diabetes ( EASD ). Diabetologia [Internet]. 2018; Available from: https://doi.org/10.1007/s00125-018-4729-5

    Article  Google Scholar 

  10. Shivaswamy V, Boerner B, Larsen J. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr Rev [Internet]. 2016 Feb [cited 2018 Jan 5];37(1):37–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26650437

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Zydus Hospitals, Ahmedabad, India

    Om J. Lakhani

Authors
  1. Om J. Lakhani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Om J. Lakhani.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lakhani, O.J. Management of new onset diabetes after transplantation (NODAT) with use of novel algorithm. Int J Diabetes Dev Ctries 39, 768–773 (2019). https://doi.org/10.1007/s13410-019-00741-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-019-00741-2

Keywords

Search

Navigation